{{Rsnum
|rsid=705471
|Chromosome=10
|position=3667726
|Orientation=plus
|GMAF=0.3223
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 38.1 | 46.0 | 15.9
| HCB | 46.3 | 43.3 | 10.4
| JPT | 59.3 | 39.8 | 0.9
| YRI | 48.3 | 41.5 | 10.2
| ASW | 52.6 | 42.1 | 5.3
| CHB | 46.3 | 43.3 | 10.4
| CHD | 46.8 | 45.9 | 7.3
| GIH | 67.0 | 28.0 | 5.0
| LWK | 49.5 | 45.8 | 4.7
| MEX | 48.3 | 37.9 | 13.8
| MKK | 55.2 | 37.7 | 7.1
| TSI | 44.1 | 45.1 | 10.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22864933
  |Trait=Capecitabine sensitivity
  |Title=Identification of novel germline polymorphisms governing capecitabine sensitivity.
  |RiskAllele=
  |Pval=7E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}